Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Valdivieso

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Statistical Methods in Medical Research|June 7, 2024
A robust regression model for bounded count health dataCristian L Bayes, Jorge Luis Bazán, Luis Valdivieso
Antibodies (Basel, Switzerland)|August 9, 2020
Solutions to Avoid False Positives for Rituximab in Pre-Transplant CrossmatchesArgentina Colmenero Velazquez, Ignacio Iturrieta-Zuazo, Juan Luis Valdivieso Shephard, et al.
Rheumatology (Oxford, England)|December 5, 2021
Hypomorphic variant in TRNT1 induces a milder autoinflammatory disease with congenital cataracts and impaired sexual developmentMaría Bravo García-Morato, Beatriz Padilla-Merlano, Elisabet Matas Pérez, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|February 8, 2024
The challenge of standardizing CAR-T cell monitoring: A comparison of two flow-cytometry methods and correlation with qPCR techniqueJuan Luis Valdivieso-Shephard, Elisabet Matas-Pérez, Silvia García-Bujalance, et al.
BMC Cancer|October 22, 2025
Real-world evidence in localized and locally advanced prostate cancer: applying artificial intelligence to electronic health recordsJosé Pablo Maroto, Javier Puente, Antonio Conde Moreno, et al.
Heliyon|January 1, 2024
Predicting anti-TNF treatment response in rheumatoid arthritis: An artificial intelligence-driven model using cytokine profile and routine clinical practice parametersJuan Luis Valdivieso Shephard, Enrique Josue Alvarez Robles, Carmen Cámara Hijón, et al.
Clinical Immunology (Orlando, Fla.)|July 30, 2021
Variants in CASP10, a diagnostic challenge: Single center experience and review of the literatureElisabet Matas Pérez, Juan Luis Valdivieso Shephard, María Bravo García-Morato, et al.
Advances in Laboratory Medicine|May 15, 2026
Pharmacogenetic biomarkers for predicting therapeutic response to JAK inhibitors in rheumatoid arthritisChamaida Plasencia-Rodríguez, Marta Novella-Navarro, Juan Luis Valdivieso Shephard, et al.
Blood Cells, Molecules & Diseases|June 27, 2021
Hematologically important mutations: X-linked chronic granulomatous disease (fourth update)Dirk Roos, Karin van Leeuwen, Amy P Hsu, et al.
Blood Cells, Molecules & Diseases|September 21, 2021
Hematologically important mutations: The autosomal forms of chronic granulomatous disease (third update)Dirk Roos, Karin van Leeuwen, Amy P Hsu, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Statistical Methods in Medical Research|June 7, 2024
A robust regression model for bounded count health dataCristian L Bayes, Jorge Luis Bazán, Luis Valdivieso
Antibodies (Basel, Switzerland)|August 9, 2020
Solutions to Avoid False Positives for Rituximab in Pre-Transplant CrossmatchesArgentina Colmenero Velazquez, Ignacio Iturrieta-Zuazo, Juan Luis Valdivieso Shephard, et al.
Rheumatology (Oxford, England)|December 5, 2021
Hypomorphic variant in TRNT1 induces a milder autoinflammatory disease with congenital cataracts and impaired sexual developmentMaría Bravo García-Morato, Beatriz Padilla-Merlano, Elisabet Matas Pérez, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|February 8, 2024
The challenge of standardizing CAR-T cell monitoring: A comparison of two flow-cytometry methods and correlation with qPCR techniqueJuan Luis Valdivieso-Shephard, Elisabet Matas-Pérez, Silvia García-Bujalance, et al.
BMC Cancer|October 22, 2025
Real-world evidence in localized and locally advanced prostate cancer: applying artificial intelligence to electronic health recordsJosé Pablo Maroto, Javier Puente, Antonio Conde Moreno, et al.
Heliyon|January 1, 2024
Predicting anti-TNF treatment response in rheumatoid arthritis: An artificial intelligence-driven model using cytokine profile and routine clinical practice parametersJuan Luis Valdivieso Shephard, Enrique Josue Alvarez Robles, Carmen Cámara Hijón, et al.
Clinical Immunology (Orlando, Fla.)|July 30, 2021
Variants in CASP10, a diagnostic challenge: Single center experience and review of the literatureElisabet Matas Pérez, Juan Luis Valdivieso Shephard, María Bravo García-Morato, et al.
Advances in Laboratory Medicine|May 15, 2026
Pharmacogenetic biomarkers for predicting therapeutic response to JAK inhibitors in rheumatoid arthritisChamaida Plasencia-Rodríguez, Marta Novella-Navarro, Juan Luis Valdivieso Shephard, et al.
Blood Cells, Molecules & Diseases|June 27, 2021
Hematologically important mutations: X-linked chronic granulomatous disease (fourth update)Dirk Roos, Karin van Leeuwen, Amy P Hsu, et al.
Blood Cells, Molecules & Diseases|September 21, 2021
Hematologically important mutations: The autosomal forms of chronic granulomatous disease (third update)Dirk Roos, Karin van Leeuwen, Amy P Hsu, et al.
Pageof 1